RETRACTED ARTICLE:The association of Crk-like adapter protein with poor prognosis in glioma patients

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5695-5700

  Yao, Chengjun ^a   Lv, Shunzeng ^b,d   Han, Mingzhi ^b   Zhang, Jie ^c,d   Zhang, Ya ^e   Zhang, Li ^b,d   Yi, Ruiyang ^f   Zhuang, Dongxiao ^a   Wu, Jinsong ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^e SHANDONG UNIVERSITY   (China)

^f University of Chicago   (United States)

Author keywords

CrkL; Glioma; Immunohistochemistry; Prognosis

Indexed keywords

CRK LIKE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; CORRELATIONAL STUDY; FEMALE; FOLLOW UP; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; WESTERN BLOTTING; WORLD HEALTH ORGANIZATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NUCLEAR PROTEINS; PROGNOSIS;

EID: 84904767871     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1754-y     Document Type: TB

References (21)

1. Lv S, Qin J, Yi R, Coreman M, Shi R, Kang H, et al. Crkl efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma. J Mol Neurosci. 2013;51:1046-51.
2. Butowski NA, Chang SM. Glial tumors: the current state of scientific knowledge. Clin Neurosurg. 2006;53:106-13.
3. Kleihues P, Sobin LH. World Health Organization classification of tumors. Cancer. 2000;88:2887. (Pubitemid 30417954)
4. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109:93-108. (Pubitemid 40287792)
5. Feller SM. Crk family adaptors-signalling complex formation and biological roles. Oncogene. 2001;20:6348-71. (Pubitemid 32977844)
6. Sriram G, Birge RB. Emerging roles for Crk in human cancer. Genes Cancer. 2010;1:1132-9.
7. Yanagi H, Wang L, Nishihara H, Kimura T, Tanino M, Yanagi T, et al. CRKL plays a pivotal role in tumorigenesis of head and neck squamous cell carcinoma through the regulation of cell adhesion. Biochem Biophys Res Commun. 2012;418:104-9.
8. Birge RB, Kalodimos C, Inagaki F, Tanaka S. Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun Signal. 2009;7:13.
9. Zhao T, Miao Z, Wang Z, Xu Y, Wu J, Liu X, et al. Overexpression of CRKL correlates with malignant cell proliferation in breast cancer. Tumour Biol. 2013;34:2891-7.
10. Wang Y, Dong QZ, Fu L, Stoecker M, Wang E, Wang EH. Overexpression of Crkl correlates with poor prognosis and cell proliferation in non-small cell lung cancer. Mol Carcinog. 2013;52:890-9.
11. Cheung HW, Du J, Boehm JS, He F, Weir BA, Wang X, et al. Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers. Cancer Discov. 2011;1:608-25.
12. Wang J, Che YL, Li G, Liu B, Shen TM, Wang H, et al. Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma. Mol Carcinog. 2011;50:506-15.
13. Chiu ST, Chang KJ, Ting CH, Shen HC, Li H, Hsieh FJ. Overexpression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells. Carcinogenesis. 2009;30:1475-86.
14. Hernández-Boluda JC, Cervantes F. Prognostic factors in chronic myeloid leukaemia. Best Pract Res Clin Haematol. 2009;22:343-53.
15. Evren S, Ma XZ, Sakac D, Branch DR. SHP-1 protein tyrosine phosphatase associates with the adaptor protein CrkL. Exp Hematol. 2012;40:1055-9.
16. Singer CF, Hudelist G, Lamm W, Mueller R, Handl C, Kubista E, et al. Active (p)CrkL is overexpressed in human malignancies: potential role as a surrogate parameter for therapeutic tyrosine kinase inhibition. Oncol Rep. 2006;15:353-9.
17. Bell ES, Park M. Models of Crk adaptor proteins in cancer. Genes Cancer. 2012;3:341-52.
18. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, et al. Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK. Nat Struct Mol Biol. 2007;14:503-10. (Pubitemid 46871805)
19. Graf R, Barbero S, Keller N, Chen L, Uryu S, Schlaepfer D, et al. Src-inducible association of CrkL with procaspase-8 promotes cell migration. Cell Adh Migr. 2013;7:362-9.
20. Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, et al. Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma. Mol Cell Proteomics. 2013;12:1335-49.
21. Kim YH, Kwei KA, Girard L, Salari K, Kao J, Pacyna-Gengelbach M, et al. Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer. Oncogene. 2010;29:1421-30.